|
RCOR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75199999999931E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.54650000051238E-07 |
| Normal-vs-Stage2 |
8.639700E-02 |
| Normal-vs-Stage3 |
2.069600E-02 |
| Normal-vs-Stage4 |
4.101700E-02 |
| Stage1-vs-Stage2 |
3.018000E-01 |
| Stage1-vs-Stage3 |
3.714600E-01 |
| Stage1-vs-Stage4 |
8.872200E-01 |
| Stage2-vs-Stage3 |
8.465400E-01 |
| Stage2-vs-Stage4 |
4.921600E-01 |
| Stage3-vs-Stage4 |
5.506400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.48970000002357E-06 |
| Normal-vs-AfricanAmerican |
1.267800E-02 |
| Normal-vs-Asian |
5.300600E-01 |
| Caucasian-vs-AfricanAmerican |
2.507800E-01 |
| Caucasian-vs-Asian |
3.776600E-01 |
| AfricanAmerican-vs-Asian |
7.481400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.04149999963421E-07 |
| Normal-vs-Female |
1.351620E-01 |
| Male-vs-Female |
6.284900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.143500E-03 |
| Normal-vs-Extreme_Weight |
1.17240000041541E-07 |
| Normal-vs-Obese |
2.016000E-02 |
| Normal-vs-Extreme_Obese |
5.962700E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.134800E-01 |
| Normal_Weight-vs-Obese |
2.850600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.589200E-01 |
| Extreme_Weight-vs-Obese |
1.510100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.908200E-01 |
| Obese-vs-Extreme_Obese |
4.209000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.041200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.302200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.524399999564E-07 |
| Normal-vs-Age(81-100Yrs) |
3.973200000007E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.385200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.910200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.362400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.704400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.975700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.142200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.10299999999775E-05 |
| Normal-VS-Type2 PRCC |
1.9660000000199E-06 |
| Normal-VS-KIRP CIMP |
9.845600E-01 |
| Normal-VS-Unclassified PRCC |
1.006600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.392600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.800230E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.589200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.341820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.529350E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.010600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00839999683799E-08 |
| Normal-vs-N1 |
5.290000E-01 |
| Normal-vs-N2 |
8.012500E-04 |
| N0-vs-N1 |
1.553560E-02 |
| N0-vs-N2 |
3.249000E-01 |
| N1-vs-N2 |
1.272760E-01 |
|
|
